Calidi (CLDI) Biotherapeutics announced that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-12. The company’s common stock is expected to commence trading on a split-adjusted basis when the NYSE American market opens on August 5 under the existing symbol of “CLDI.” The new CUSIP number for the company’s common stock following the reverse stock split will be 320703 408.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLDI: